Nicholas Bingham, MBBS, FRACP, FRCPA, Alfred Health & Monash University, Melbourne, Australia, discusses research in which whole-genome sequencing (WGS) was used to investigate the role of small nucleotide variants (SNVs), copy number variants (CNVs) and structural variants (SVs) in patients with extramedullary multiple myeloma. This interview took place at the 20th International Myeloma Society (IMS) Annual Meeting, held in Athens, Greece.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.